A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSION

April 13, 2020 updated by: Abramson Cancer Center of the University of Pennsylvania
To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical professionals)

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Abramson Cancer Center of The University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

A healthcare professional, a patient or caregiver in the Radiation Oncology Department at the University of Pennsylvania

Description

Inclusion Criteria:

  • Adults between the age of 18 - 70
  • A healthcare professional, a patient or caregiver in the Radiation Oncology Department at the University of Pennsylvania
  • Subjects must be capable of giving informed consent

Exclusion Criteria:

  • Any healthcare professional or patient/caregiver not working in or being seen at Radiation Oncology Department at the University of Pennsylvania

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
NUmber of changes in levels of stress and immune function in patients and caregivers
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Abramson Cancer Center of the University of Pennsylvania

Investigators

  • Principal Investigator: William Levin, MD, Abramson Cancer Center of The University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2017

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

May 15, 2017

First Submitted That Met QC Criteria

May 15, 2017

First Posted (Actual)

May 16, 2017

Study Record Updates

Last Update Posted (Actual)

April 15, 2020

Last Update Submitted That Met QC Criteria

April 13, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UPCC 01017

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania

  • University of California, San Francisco
    University of California, Davis
    Not yet recruiting
    RCT of HeartBot in Women (HeartBot II)
    Participants Must be Women Aged 25 Years or Older | Participants Should Have no Self-reported History of Heart Disease or Stroke | Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease | Participants Should Not be a Healthcare Professionals... and other conditions
    United States
  • American University of Beirut Medical Center
    Completed
    Ultrasound-Guided vs Landmark Technique for Femoral Arterial Cannulation in Pediatric Cardiac Surgery
    Time Needed to Achieve a Successful Cannulation of the Femoral Artery in Pediatric Cardiac Surgery
    Lebanon
  • Kırıkkale University
    Enrolling by invitation
    The Use of Lung Ultrasonography in the Delivery Room in Neonates (LUSIN)
    Suspected Damage to Fetus From Other Disease in the Mother, Affecting Management of Mother, With Delivery | Patient Death or Serious Disability Associated With A Haemolytic Reaction Due to the Administration of ABO-Incompatible Blood or Blood Products
    Turkey
  • Karolinska Institutet
    Region Stockholm
    Recruiting
    Feeding Difficulties and Quality of Life in Children With Tracheal Cannula
    Tracheostomy | Swallowing Difficulties | Children in the Pediatric Intensive Care Unit or General Pediatric Care Unit Requiring a Central Venous Catheter | Feeding Difficulties | Caregiver Quality of Life | Quality of Life (QOL)
    Sweden
  • Centre Hospitalier Universitaire de Liege
    Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators
    Completed
    Baby Detect : Genomic Newborn Screening (BabyDetect)
    Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions
    Belgium

Clinical Trials on Art therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe